[go: up one dir, main page]

FI813567L - Till c-3 anslutna 1,4-dihydropyridiner deras anvaendning i laekemedel och foerfarande foer deras framstaellning - Google Patents

Till c-3 anslutna 1,4-dihydropyridiner deras anvaendning i laekemedel och foerfarande foer deras framstaellning

Info

Publication number
FI813567L
FI813567L FI813567A FI813567A FI813567L FI 813567 L FI813567 L FI 813567L FI 813567 A FI813567 A FI 813567A FI 813567 A FI813567 A FI 813567A FI 813567 L FI813567 L FI 813567L
Authority
FI
Finland
Prior art keywords
carbon atoms
different
phenyl
alkyl
hydroxyl
Prior art date
Application number
FI813567A
Other languages
English (en)
Inventor
Siegfried Goldmann
Andreas Knorr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI813567L publication Critical patent/FI813567L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI813567A 1980-11-13 1981-11-11 Till c-3 anslutna 1,4-dihydropyridiner deras anvaendning i laekemedel och foerfarande foer deras framstaellning FI813567L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803042769 DE3042769A1 (de) 1980-11-13 1980-11-13 C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
FI813567L true FI813567L (fi) 1982-05-14

Family

ID=6116648

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813567A FI813567L (fi) 1980-11-13 1981-11-11 Till c-3 anslutna 1,4-dihydropyridiner deras anvaendning i laekemedel och foerfarande foer deras framstaellning

Country Status (16)

Country Link
EP (1) EP0052300B1 (fi)
JP (1) JPS57109766A (fi)
AT (1) ATE11773T1 (fi)
AU (1) AU546605B2 (fi)
CA (1) CA1179342A (fi)
DD (1) DD201900A5 (fi)
DE (2) DE3042769A1 (fi)
DK (1) DK501881A (fi)
ES (3) ES507080A0 (fi)
FI (1) FI813567L (fi)
GR (1) GR76338B (fi)
HU (1) HU186438B (fi)
IL (1) IL64253A (fi)
NO (1) NO813649L (fi)
PT (1) PT73920B (fi)
ZA (1) ZA817840B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0145956A1 (de) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Neue Amid-Verbindungen
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
IT1203900B (it) * 1987-04-15 1989-02-23 Lagor Spa Poli 1,4-diidro-2,6-dimetilpiridine 3,5-dicarbossilesteri utili come stabilizzanti termici per polimeri sintetici
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Dicitons are converted into alkanyl or ethylmethylene, through their preparation and pharmaceutical preparations containing them
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
US5185370A (en) * 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
US6897305B2 (en) 1998-06-08 2005-05-24 Theravance, Inc. Calcium channel drugs and uses
WO1999063992A1 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. Novel calcium channel drugs and uses
US7101909B2 (en) 1998-10-12 2006-09-05 Theravance, Inc. Calcium channel drugs and uses
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795788A1 (de) * 1966-11-16 1975-07-31 Astra Ab Pyridinderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
IL64253A0 (en) 1982-02-28
AU546605B2 (en) 1985-09-12
ES510254A0 (es) 1983-02-01
IL64253A (en) 1985-03-31
CA1179342A (en) 1984-12-11
DE3042769A1 (de) 1982-06-09
HU186438B (en) 1985-07-29
DE3168955D1 (en) 1985-03-28
ZA817840B (en) 1982-10-27
DK501881A (da) 1982-05-14
PT73920B (en) 1983-03-29
ATE11773T1 (de) 1985-02-15
ES8206477A1 (es) 1982-08-16
NO813649L (no) 1982-05-14
AU7711081A (en) 1982-05-20
EP0052300A1 (de) 1982-05-26
GR76338B (fi) 1984-08-04
PT73920A (en) 1981-12-01
ES507080A0 (es) 1982-08-16
JPS57109766A (en) 1982-07-08
ES8303336A1 (es) 1983-02-01
DD201900A5 (de) 1983-08-17
ES8303337A1 (es) 1983-02-01
EP0052300B1 (de) 1985-02-13
ES510253A0 (es) 1983-02-01

Similar Documents

Publication Publication Date Title
FI813567L (fi) Till c-3 anslutna 1,4-dihydropyridiner deras anvaendning i laekemedel och foerfarande foer deras framstaellning
NO850315L (no) Fremgangsmaate for fremstilling av metylendifosfonsyre-derivater med antireumatiske egenskaper
DK416184D0 (da) Flaven- og thioflavenderivater og salte deraf samt deres fremstilling og anvendelse
KR840000493A (ko) 피리딘으로부터 유도된 아미드 및 에스테르기를 포함하는 제초제의 제조방법
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
SE7901715L (sv) Nya pyrrolidin-2-on-derivat och herbicida kompositioner innehallande desamma
ATE90939T1 (de) (thio)benzoylharnstoffe und deren funktionelle derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als schaedlingsbekaempfungsmittel.
ATE16803T1 (de) Verfahren zur herstellung von 3-(n-arylamino)tetrahydrothiophen-2-on-derivaten.
ES457575A2 (es) Procedimiento para la preparacion de un compuesto diarilico sulfurado ynu oxigenado.
ES2033544T3 (es) Procedimiento para la preparacion de compuesto polifluorados.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT